182 related articles for article (PubMed ID: 29670141)
21. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
[TBL] [Abstract][Full Text] [Related]
22. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
Vychytilova-Faltejskova P; Radova L; Sachlova M; Kosarova Z; Slaba K; Fabian P; Grolich T; Prochazka V; Kala Z; Svoboda M; Kiss I; Vyzula R; Slaby O
Carcinogenesis; 2016 Oct; 37(10):941-950. PubMed ID: 27485599
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
[TBL] [Abstract][Full Text] [Related]
24. Confirmation of a metastasis-specific microRNA signature in primary colon cancer.
Coebergh van den Braak RRJ; Sieuwerts AM; Lalmahomed ZS; Smid M; Wilting SM; Bril SI; Xiang S; van der Vlugt-Daane M; de Weerd V; van Galen A; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; ; Martens JWM; IJzermans JNM
Sci Rep; 2018 Mar; 8(1):5242. PubMed ID: 29588449
[TBL] [Abstract][Full Text] [Related]
25. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
[TBL] [Abstract][Full Text] [Related]
26. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.
Lee KH; Lee JK; Choi DW; Do IG; Sohn I; Jang KT; Jung SH; Heo JS; Choi SH; Lee KT
Pancreas; 2015 Jul; 44(5):764-8. PubMed ID: 25906450
[TBL] [Abstract][Full Text] [Related]
27. Four microRNAs Signature for Survival Prognosis in Colon Cancer using TCGA Data.
Xu J; Zhao J; Zhang R
Sci Rep; 2016 Dec; 6():38306. PubMed ID: 27974852
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
Schetter AJ; Leung SY; Sohn JJ; Zanetti KA; Bowman ED; Yanaihara N; Yuen ST; Chan TL; Kwong DL; Au GK; Liu CG; Calin GA; Croce CM; Harris CC
JAMA; 2008 Jan; 299(4):425-36. PubMed ID: 18230780
[TBL] [Abstract][Full Text] [Related]
30. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
32. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-139-3p indicates a poor prognosis of colon cancer.
Liu X; Duan B; Dong Y; He C; Zhou H; Sheng H; Gao H; Zhang X
Int J Clin Exp Pathol; 2014; 7(11):8046-52. PubMed ID: 25550849
[TBL] [Abstract][Full Text] [Related]
34. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
35. A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine.
Fredsøe J; Rasmussen AKI; Mouritzen P; Borre M; Ørntoft T; Sørensen KD
Int J Cancer; 2019 Nov; 145(9):2558-2567. PubMed ID: 30903800
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
37. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.
Oue N; Anami K; Schetter AJ; Moehler M; Okayama H; Khan MA; Bowman ED; Mueller A; Schad A; Shimomura M; Hinoi T; Aoyagi K; Sasaki H; Okajima M; Ohdan H; Galle PR; Yasui W; Harris CC
Int J Cancer; 2014 Apr; 134(8):1926-34. PubMed ID: 24122631
[TBL] [Abstract][Full Text] [Related]
38. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
[TBL] [Abstract][Full Text] [Related]
39. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Chen XY; Zhang J; Hou LD; Zhang R; Chen W; Fan HN; Huang YX; Liu H; Zhu JS
Int J Immunopathol Pharmacol; 2018; 32():2058738418790318. PubMed ID: 30045644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
